NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,160 filers reported holding NOVARTIS A G in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,790,948 | +1.8% | 155,026 | +0.8% | 1.16% | +6.9% |
| Q2 2023 | $15,515,619 | +9.8% | 153,757 | +0.1% | 1.08% | +9.8% |
| Q1 2023 | $14,131,292 | +2.4% | 153,601 | +1.0% | 0.99% | -2.1% |
| Q4 2022 | $13,795,155 | +30.4% | 152,063 | +9.2% | 1.01% | +16.8% |
| Q3 2022 | $10,580,000 | -9.0% | 139,203 | +1.3% | 0.86% | -5.6% |
| Q2 2022 | $11,620,000 | -1.2% | 137,469 | +2.5% | 0.92% | +14.7% |
| Q1 2022 | $11,760,000 | +3.8% | 134,065 | +3.5% | 0.80% | +9.5% |
| Q4 2021 | $11,330,000 | +10.2% | 129,585 | +3.1% | 0.73% | +1.5% |
| Q3 2021 | $10,280,000 | -15.3% | 125,645 | -5.5% | 0.72% | -14.4% |
| Q2 2021 | $12,130,000 | +9.9% | 132,939 | +3.0% | 0.84% | +1.7% |
| Q1 2021 | $11,040,000 | -11.0% | 129,115 | -1.7% | 0.82% | -15.2% |
| Q4 2020 | $12,400,000 | +8.1% | 131,318 | -0.4% | 0.97% | -5.8% |
| Q3 2020 | $11,470,000 | +1.3% | 131,898 | +1.8% | 1.03% | -5.7% |
| Q2 2020 | $11,320,000 | +6.4% | 129,628 | +0.5% | 1.10% | -12.7% |
| Q1 2020 | $10,638,000 | -11.6% | 129,023 | +1.6% | 1.25% | +14.4% |
| Q4 2019 | $12,029,000 | +10.4% | 127,038 | +1.3% | 1.10% | +2.2% |
| Q3 2019 | $10,894,000 | -3.3% | 125,358 | +1.6% | 1.07% | -3.7% |
| Q2 2019 | $11,263,000 | -4.9% | 123,353 | +0.2% | 1.11% | -9.7% |
| Q1 2019 | $11,841,000 | +11.1% | 123,161 | -0.8% | 1.23% | -2.2% |
| Q4 2018 | $10,654,000 | -0.6% | 124,161 | -0.2% | 1.26% | +14.1% |
| Q3 2018 | $10,719,000 | +15.7% | 124,406 | +1.4% | 1.10% | +8.5% |
| Q2 2018 | $9,266,000 | -5.3% | 122,662 | +1.3% | 1.02% | -6.8% |
| Q1 2018 | $9,787,000 | -1.2% | 121,052 | +2.6% | 1.09% | +3.3% |
| Q4 2017 | $9,903,000 | +1.9% | 117,947 | +4.2% | 1.06% | -3.1% |
| Q3 2017 | $9,722,000 | +19.2% | 113,247 | +15.9% | 1.09% | +13.3% |
| Q2 2017 | $8,153,000 | +16.1% | 97,672 | +3.3% | 0.96% | +11.1% |
| Q1 2017 | $7,023,000 | +3.7% | 94,567 | +1.7% | 0.87% | -1.3% |
| Q4 2016 | $6,773,000 | -1.2% | 92,987 | +7.1% | 0.88% | -2.6% |
| Q3 2016 | $6,857,000 | +18.3% | 86,842 | +23.6% | 0.90% | +11.1% |
| Q2 2016 | $5,795,000 | +80.8% | 70,237 | +58.8% | 0.81% | +74.8% |
| Q1 2016 | $3,205,000 | +31.0% | 44,243 | +55.6% | 0.46% | +24.7% |
| Q4 2015 | $2,446,000 | +53.5% | 28,428 | +63.9% | 0.37% | +39.3% |
| Q3 2015 | $1,594,000 | +50.7% | 17,344 | +61.2% | 0.27% | +64.8% |
| Q2 2015 | $1,058,000 | -0.3% | 10,758 | 0.0% | 0.16% | 0.0% |
| Q1 2015 | $1,061,000 | +4.6% | 10,758 | -1.6% | 0.16% | +3.2% |
| Q4 2014 | $1,014,000 | -2.7% | 10,938 | -1.1% | 0.16% | -4.3% |
| Q3 2014 | $1,042,000 | +6.7% | 11,065 | +2.5% | 0.16% | +11.6% |
| Q2 2014 | $977,000 | +6.3% | 10,792 | -0.1% | 0.15% | +2.1% |
| Q1 2014 | $919,000 | +1.9% | 10,805 | -3.7% | 0.14% | -2.0% |
| Q4 2013 | $902,000 | +4.4% | 11,217 | -0.4% | 0.15% | -4.5% |
| Q3 2013 | $864,000 | -0.6% | 11,260 | -8.3% | 0.15% | -6.7% |
| Q2 2013 | $869,000 | – | 12,285 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |